Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL

Enrollment

209

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

February 29, 2008

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Sitagliptin phosphate

50 mg QD or 100 mg QD for 12 months

Trial Locations (8)

Chugoku Region, Chugoku

Chubu Region, Chūbu

Hokkaido Region, Hokkaido

Kanto Region, Kanto

Kinki Region, Kinki

Kyushu Region, Kyushu

Shikoku Region, Shikoku

Tohoku Region, Tōhoku